Applications
Industries can be made more efficient using Atana
Team
Atanaâs team has over 50+ years of combined experience across the Stanford and Johns Hopkins University communities.
David Shi
CEO & Co-Founder
David Shi
CEO & Co-Founder
Led multiple M&A transactions. Technical consultant for Aeternity Blockchain. Advisor for blockchain companies. Awarded by Booz Allen Hamilton and J.P. Morgan for blockchain implementations. Johns Hopkins University.
Kevin Joo
CTO & Co-Founder
Kevin Joo
CTO & Co-Founder
10 years in academic and industry R&D. Led the data science team at a FDA-approved digital therapeutic startup, focusing on creating compliant APIs and a data science platform for AI-driven analyses. Johns Hopkins University.
Eric Bridgeford
VP of Engineering
Eric Bridgeford
VP of Engineering
Creator of open-source data analytics packages with emphasis on dimensionality reduction, dependence testing, and graph inference. Co-created pipeline for hyper-parallelization of dMRI and fMRI connectomics. Johns Hopkins University.
Advisory Board
Matthew Green, Ph.D
Founding Scientist, Zcash
Matthew Green, Ph.D
Founding Scientist, Zcash
Assistant Professor at the Johns Hopkins University and the JHU Information Security Institute. Creator of the Zerocoin protocol and developed the first zk-SNARK implementation in a cryptocurrency. Founding scientist of Zcash. Co-founder and former partner at Independent Security Evaluators.
Professor Green studied computer science at Oberlin College and received his doctorate degree in computer science from the Johns Hopkins University.
Steve Hanke, Ph.D
Professor of Economics, Johns Hopkins University
Steve Hanke, Ph.D
Professor of Economics, Johns Hopkins University
Professor of Applied Economics at the Johns Hopkins University and Director of the Johns Hopkins Institute for Applied Economics and Global Health. Formerly Senior Economist to President Reagan's Council of Economic Advisors and Senior Advisor to the Joint Economic Committee of the U.S. Congress. Senior Fellow and Director of the Troubled Currencies Project at the Cato Institute, Senior Advisor to China's International Monetary Research Institute. Former State Counselor to Lithuania and Montenegro, and Advisor to the Presidents of Bulgaria, Venezuela, and Indonesia. Reformed currencies and advised governments of many states including Argentina, the United Arab Emirates, Estonia, Kazakhstan, and Russia.
Professor Hanke studied business administration and received his doctorate degree in economics from the University of Colorado.
Anita Cattrell, Ph.D
Chief Innovation Officer, Evolent Health
Anita Cattrell, Ph.D
Chief Innovation Officer, Evolent Health
Chief Innovation Officer and former Senior Vice President of Research and Development at Evolent Health. Dr. Cattrell holds a PhD in Clinical Epidemiology from Harvard University and has spent that last 10 years building risk models and evaluating the impact of clinical programs for the National Institutes of Health, the Department of Defense, the Centers for Disease Control, and USAID. Prior to joining Evolent, Dr. Cattrell served as a Senior Associate at Booz Allen Hamilton building the firmâs Evaluation Practice and prior to that was the Director of Monitoring and Evaluation for Partners in Health, Rwanda.
Dr. Cattrell studied biomedical engineering at Northwestern University and received her masterâs degree in biomedical engineering and doctorate degree in epidemiology from Harvard University.
Matthew Cunningham
Executive Vice President, eviCore
Matthew Cunningham
Executive Vice President, eviCore
Executive Vice President of Utilization Management at eviCore. Matt oversees strategic transformation of utilization management business with a focus on reducing burden of prior authorization process through EHR connectivity, integration of natural language and advanced data science techniques to automate administrative and clinical processes and developing value added services designed assist in evidence based clinical decision making at the point of care. Matt joined eviCore in 2004 as the Director of Call Center Operations. During his tenure at eviCore, he has also served as SVP of Value Improvement Programs, SVP of Information Technology, SVP of Program Operations, SVP of Call Center Operations, and VP of Management Engineering. Prior to joining eviCore, Matt served as an Infantry Officer in the U.S. Army for nearly nine years.
Matt studied civil engineering at the United States Military Academy at West Point.
Christopher Ensey
Chief Operating Officer, Riot Blockchain
Christopher Ensey
Chief Operating Officer, Riot Blockchain
COO at Riot Blockchain. Previously COO at Dunbar and founder of Dunbarâs cybersecurity business. Experienced cybersecurity executive and creator of the Cyphon enterprise cybersecurity platform. Virginia Tech.
Chris studied computer engineering at Virginia Tech University.
Michael Doyle, FACHE
President and CEO, QPID Health
Michael Doyle, FACHE
President and CEO, QPID Health
President and CEO at QPID Health (acquired by Evicore). Prior to QPID, Mike was CEO and Chairman of Medsphere Systems Corporation, the developer of OpenVista, an open-source enterprise electronic health record system whose basic source code originated at the VA. While President and CEO of Advantedge Health Solutions, he led the rapid expansion of a cloud based physician revenue cycle management solution for hospital-based physicians. As founder, CEO, and President of Standish Care (CareMatrix), a company he brought public, Mike created the âassisted livingâ category of long term care. He previously held senior leadership positions with two major integrated healthcare delivery systems: Voluntary Hospitals of America (VHA) and National Medical Enterprises (Tenet).
Mike studied biology and community health at Tufts University and received his MBA in finance and hospital administration from the University of Chicago.
Roger Sawhney, M.D.
Partner, Bain & Company
Roger Sawhney, M.D.
Partner, Bain & Company
Senior Vice President of Outcome Health. At Outcome Health, Dr. Sawhney leads their corporate strategy and go-to-market efforts and manages their $100M venture fund. He has developed $25M+ of business relationships for Outcome, including Medisafe, Vivify, Novartis, Bayer, Amgen, Celgene, Gilead, and AbbVie. Before Outcome, Dr. Sawhney served as a partner in Bain's private equity and healthcare division, leading strategy for payers and life sciences firms as well as investment strategy for Bain's healthcare Partner Fund. He has also served as the SVP and head of corporate strategy at Novartis Pharmaceuticals, where he led mergers and acquisitions, partnership strategy, and go-to-market efforts. Previous to Novartis, Dr. Sawhney was a partner and managing director at Boston Consulting Group, where he was responsible for their healthcare practices division and generated $150MM in engagements in the biopharma and medical device industry. Dr. Sawhney also founded and managed Avatar Capital, an early-stage fund that generated 6.2x cash-on-cash returns through successful exists such as Cvent's $1.5B IPO.
Dr. Sawhney studied economics at Stanford University and received his doctorate degree in medicine from Harvard University.
John Lin, Ph.D
Executive Vice President, Frontage Labs
John Lin, Ph.D
Executive Vice President, Frontage Labs
Executive Vice President at Frontage Labs ($40M in annual revenue). Dr. Lin leads the CRO's Bioanalytical and Biologics Services unit, commanding operations for the company's global bioanalytics labs. Previously, Dr. Lin was head of AstraZeneca Pharmaceuticals' global Drug Metabolism and Pharmokinetics division.
Dr. Lin studied chemistry at Jiangxi Normal College and received his doctorate degree in analytical chemistry from Dalhousie University. He completed his post-doctoral research in pharmacokinetics and drug metabolism at the College of Pharmacy and the Comprehensive Cancer Center of the Ohio State University.
Ruben Amarasingham, M.D.
Founder and CEO, Pieces Technologies
Ruben Amarasingham, M.D.
Founder and CEO, Pieces Technologies
Founder and CEO at Pieces Technologies, and inventor of the Pieces⢠DS software system. Inaugural Director of the Biomedical Informatics Program for the NIH CTSA at UTSW. Member of the HIMSS Board of Directors. Dr. Amarasingham has conducted and published studies in health IT evaluation, electronic medical records (EMR)-based enterprise-wide quality improvement, and real-time health predictive analysis, and he has won over $28M in extramural research funding in these areas.
Dr. Amarasingham studied at Brown University and received his doctorage degree in medicine from the University of Texas at Dallas. He was a Robert Wood clinical scholar at the Johns Hopkins University, where he focused on health service research and biomedical informatics.